Guangdong Jiangmen: enping stillborn unrelated to vaccination vaccine | stillborn | | _ Jiangmen news

South are appear reporter tangboenping January big baby vaccination hepatitis b vaccine Hou next death, after for more than a months of autopsy zhihou, Jiangmen Health Council held the issued informed, said by Guangdong Province, and Jiangmen, and enping three level prevention vaccination exception reaction experts according to Guangdong province suspected prevention vaccination exception reaction survey diagnosis guidelines (pilot) under, and vaccine circulation and prevention vaccination Management Ordinance under and prevention vaccination exception reaction identification way under for clinical consultation, combined Sun Yat-sen University forensic identification Center of body solutions identification results, Enping city, excluding infant hepatitis b vaccine for Li to death. According to Sun Yat-sen University Centre for forensic forensic autopsy and clinical experts to discuss: Lee meets with Interstitial pneumonia induced by acute hemorrhagic pulmonary edema deaths.

South reporter learned that, this death is a baby boy, was born in October 21, 2013 Yun Ping in a hospital, childbirth is a natural birth (35 weeks of pregnancy) and weighing 2. birth day 1 dose of 10 μg hepatitis b vaccinations. On November 27 a second dose of hepatitis b vaccine in local hospitals and vaccination process had complied with specifications, November 28 morning parents find baby exception sent to a local hospital and died. December 3 dependents without the consent of the submission.

According to the Jiangmen municipal health Bureau introduced on December 20, 2013, provincial health family planning Commission issued a temporary suspension of the forwarding State Health Commission Office on Shenzhen kangtai biological products Corporation produces recombinant hepatitis b vaccine (Saccharomyces cerevisiae) notice (letter of Yue Wei (2013)), Jiangmen city, notified the city's Health Bureau the day all vaccinations carried out, and called for the Centers for disease control and prevention at all levels to collect, Local statistics received from the Shenzhen kangtai biological products Corporation since January 1, 2013 all batches of recombinant hepatitis b vaccine (Saccharomyces cerevisiae) and their use, inventory and so on. Suspended all units throughout the city of Jiangmen, Shenzhen kangtai biological products Corporation produces recombinant hepatitis b vaccine (Saccharomyces cerevisiae), on December 24, 2013, the Centers for disease control and prevention at all levels to hepatitis b vaccination be territorial units reassigned from Beijing tiantan biological products Corporation-hepatitis b vaccine. At present, the injection of hepatitis b vaccine free of charge for school-age children in the city have been fully restored.

(Original title: enping stillborn unrelated to vaccination)

January 06, 2014 The Southern Metropolis daily
(
广东江门：恩平死婴无关接种疫苗|死婴|疫苗|江门_新闻资讯

　　南都讯 记者唐波 恩平一月大婴儿接种乙肝疫苗后次日死亡，经过一个多月的尸检之后，江门市卫生局前日发出通报，称经广东省、江门市、恩平市三级预防接种异常反应专家按照《广东省疑似预防接种异常反应调查诊断指引(试行)》、《疫苗流通和预防接种管理条例》和《预防接种异常反应鉴定办法》进行临床会诊，结合中山大学法医鉴定中心的尸解鉴定结果，排除恩平市婴儿李某某为接种乙肝疫苗致死。根据中山大学法医鉴定中心法医解剖结果及临床专家讨论：李某某符合因患间质性肺炎致急性出血性肺水肿死亡。

　　南都记者了解到，这名死亡病例是一男婴，于2013年10月21日生于恩平某医院，当时分娩是顺产(妊娠35周)，体重2 .25kg，出生当天接种1剂10微克乙肝疫苗。11月27日在当地卫生院接种第二针乙肝疫苗，接种实施过程均符合规范要求，11月28日早上起床家长发现婴儿异常，送至当地医院，经抢救无效死亡。12月3日在家属同意的情况下送检。

　　据江门市卫生局介绍，2013年12月20日，省卫生计生委下发《转发国家卫生计生委办公厅关于暂停使用深圳康泰生物制品股份有限公司生产重组乙型肝炎疫苗(酿酒酵母)的通知》(粤卫函〔2013〕1203号)，江门市卫生局当天及时通知全市所有接种单位贯彻执行，并要求各级疾病预防控制中心收集、统计本地2013年1月1日以来从深圳康泰生物制品股份有限公司接收的全部批次重组乙型肝炎疫苗(酿酒酵母)及其使用、库存等情况。江门全市所有接种单位暂停使用深圳康泰生物制品股份有限公司生产重组乙型肝炎疫苗(酿酒酵母)后，2013年12月24日，各级疾病预防控制中心给属地乙肝疫苗接种单位重新分派由北京天坛生物制品股份有限公司生产的乙肝疫苗。目前，全市为适龄儿童免费注射乙肝疫苗的工作已全面恢复。

(原标题：恩平死婴无关接种疫苗)

2014年01月06日04:30
南方都市报
)